Urology
Volume 61, Issue 6 , Pages 1146-1150 , June 2003

Cytologic analysis of ureteral washings is informative in patients with grade 2 upper tract TCC considering endoscopic treatment

  • A Skolarikos

      Affiliations

    • University Department of Urology, Freeman Hospital, Newcastle upon Tyne, United Kingdom
  • ,
  • T.R.L Griffiths

      Affiliations

    • University Department of Urology, Freeman Hospital, Newcastle upon Tyne, United Kingdom
  • ,
  • P.H Powell

      Affiliations

    • University Department of Urology, Freeman Hospital, Newcastle upon Tyne, United Kingdom
  • ,
  • D.J Thomas

      Affiliations

    • University Department of Urology, Freeman Hospital, Newcastle upon Tyne, United Kingdom
  • ,
  • D.E Neal

      Affiliations

    • University Department of Urology, Freeman Hospital, Newcastle upon Tyne, United Kingdom
  • ,
  • J.D Kelly

      Affiliations

    • University Department of Urology, Freeman Hospital, Newcastle upon Tyne, United Kingdom
    • Corresponding Author InformationReprint requests: J. D. Kelly, M.D., Department of Oncology, Addenbrookes Hospital, Box 193, Cambridge CB2 2QQ, United Kingdom

Received 5 September 2002 ,Accepted 9 January 2003.

References 

  1. Landis SH, Murray T, Bolden S, et al.  Cancer statistics 1998. CA Cancer J Clin. 1998;48:6–29
  2. Messing EM, Catalona W. Urothelial tumors of the urinary tract. In:  Walsh PC,  Retic AB,  Vaughan ED, et al. editor. Campbell’s Urology. 7th ed. Philadelphia: WB Saunders; 1998;p. 2327–2410
  3. Bloom NA, Vidone RA, Lytton B. Primary carcinoma of the ureter (a report of 102 new cases). J Urol. 1970;103:590–598
  4. Chen GL, Bagley DH. Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. J Urol. 2000;164:1173–1176
  5. Elliott DS, Segura JW, Lightner D, et al.  Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney. Urology. 2001;58:174–178
  6. Patel A, Soonawalla P, Shepherd SF, et al.  Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis. J Urol. 1996;155:868–874
  7. Elliott DS, Blute ML, Patterson DE, et al.  Long-term follow-up of endoscopically treated upper urinary tract transitional cell carcinoma. Urology. 1996;47:819–825
  8. Tawfiek ER, Bagley DH. Upper-tract transitional cell carcinoma. Urology. 1997;50:321–329
  9. Keeley F, Bibbo M, Bagley DH. Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma. J Urol. 1997;157:1560–1565
  10. Guarnizo E, Pavlovich CP, Seiba M, et al.  Ureteroscopic biopsy of upper tract urothelial carcinoma (improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach). J Urol. 2000;163:52–55
  11. Keeley FX, Kulp DA, Bibbo M, et al.  Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J Urol. 1997;157:33–37
  12. Bagley DH, Huffman JL, Lyon ES. Flexible ureteropyeloscopy (diagnosis and treatment in the upper urinary tract). J Urol. 1987;138:280–285
  13. Dodd LG, Johnston WW, Robertson CN, et al.  Endoscopic brush cytology of the upper urinary tract (evaluation of its efficacy and potential limitations in diagnosis). Acta Cytol. 1997;41:377–384
  14. Naib ZM. Exfoliative cytology of renal pelvic lesions. Cancer. 1961;14:1085–1087
  15. Mostoffi FK, Sobin LF, Torloni H. Histological Typing of Urinary Bladder Tumours, International Histological Classification of Tumours No. 10. Geneva: World Health Organization; 1973;
  16. Hermaneck P, Sobin LH (Eds) for the International Union Against Cancer: TNM Classification of Malignant Tumours, 5th ed. Berlin, Springer-Verlag, 1997
  17. Clark PE, Streem SB, Geisinger MA. 13-year experience with percutaneous management of upper tract transitional cell carcinoma. J Urol. 1999;161:772–775
  18. Murphy DM, Zinke H, Furlow WL. Primary grade I transitional cell carcinoma of the renal pelvis and ureter. J Urol. 1980;123:629–631
  19. Martinez-Pineiro JA, Matres JG, Martinez-Pineiro L. Endourological treatment of upper tract urothelial carcinoma (analysis of a series of 59 tumors). J Urol. 1996;156:377–385
  20. Carbin BE, Ekman P, Gustafson H, et al.  The grading of human urothelial carcinoma based on nuclear atypia and mitotic frequency (1. Histological description). J Urol. 1991;145:968–971
  21. Carbin BE, Ekman P, Gustafson H, et al.  The grading of human urothelial carcinoma based on nuclear atypia and mitotic frequency (2. Prognostic importance). J Urol. 1991;145:972–976
  22. Pauwels RP, Schapers RF, Smeets AW, et al.  Grading in superficial bladder cancer. (1) Morphological criteria. BJU Int. 1988;61:129–134

PII: S0090-4295(03)00026-8

doi: 10.1016/S0090-4295(03)00026-8

Urology
Volume 61, Issue 6 , Pages 1146-1150 , June 2003